Btg Intl Drug Patent Portfolio
Btg Intl owns 3 orange book drugs protected by 4 US patents Given below is the list of Btg Intl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7776838 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | 17 Aug, 2027 | Active |
| US6258795 | Acylated uridine and cytidine and uses thereof | 10 Jul, 2023 | Expired |
| US5834448 | Dosage form of hydroxocobalamin and its use in cyanide poisoning | 14 Nov, 2016 | Expired |
| US5968914 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | 19 Oct, 2016 | Expired |
Btg Intl's Drug Patent Litigations
Btg Intl's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Apr 16, 2002, against patent number US7776838. The petitioner , challenged the validity of this patent, with VON BORSTEL et al as the respondent. Click below to track the latest information on how companies are challenging Btg Intl's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US7776838 | April, 2002 |
Decision
(30 Apr, 2002)
| VON BORSTEL et al | |
Btg Intl's Family Patents
Btg Intl Drug List
Given below is the complete list of Btg Intl's drugs and the patents protecting them.
1. Cyanokit
Cyanokit is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5834448 | Dosage form of hydroxocobalamin and its use in cyanide poisoning |
14 Nov, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyanokit's drug page
2. Vistogard
Vistogard is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7776838 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
17 Aug, 2027
(2 years from now)
| Active |
| US6258795 | Acylated uridine and cytidine and uses thereof |
10 Jul, 2023
(1 year, 5 months ago)
| Expired |
| US5968914 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
19 Oct, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vistogard's drug page
3. Xuriden
Xuriden is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6258795 | Acylated uridine and cytidine and uses thereof |
10 Jul, 2023
(1 year, 5 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xuriden's drug page